Search results for #EuroPCR2023
Mirvat Alasnag, Ajay Kirtane and Flavio Ribichini discussed #ModernPCI at #EuroPCR2023. Watch the 15-minute roundtable to get an overview of the #SeePrepTreat diagnostic tools used in today’s Cath lab to treat complex lesions: bit.ly/3TdxGfY #BSCEMEA
✨BIOADAPTOR RCT trial results and conclusions! Join Dr Shigeru Saito in this exclusive presentation at #EuroPCR2023, highlighting the trial design, primary endpoint and surprising results. Don't miss out; watch the full video now [5 mins] 👉 ow.ly/11QY50PoWIi…
Gain insights from the BIOADAPTOR RCT trial with Dr Stefan Verheye in this leading-edge interview recorded at #EuroPCR2023! ow.ly/9SKR50Pg5Be ➡️What bioadaptor is and why it's different ➡️Surprises from the study ➡️Trial design #CardioEd #CardioTwitter #MedEd
🎙️ NEW video - #EuroPCR2023: BIOADAPTOR RCT results comparing novel DynamX Bioadaptor to Resolute Onyx DES with Dr Stefan Verheye! ow.ly/Fgby50PcOhY Don't miss your exclusive insights into how you can apply these results in your practice ✨ @ElixirMed
Want to know how to break the calcium ceiling in bifurcation stenosis with the new ROTAWIRE™ Drive? Access the recording of the Modern PCI TNT session chaired by Emanuele Barbato (@EmanueleBarba13). Watch it here: bit.ly/3O7uaR5 #BSCEMEA #EuroPCR2023
Watch the Philips #EuroPCR2023 symposium recording. to.philips/6015PzbWV Learn how to adopt ultra-low contrast in high-risk PCI procedures.
Watch the Philips #EuroPCR2023 symposium recording. to.philips/6017PyvPc Learn how to adopt ultra-low contrast in high-risk PCI procedures.
Watch the Philips #EuroPCR2023 symposium recording. to.philips/6012PysLp Learn how to adopt ultra-low contrast in high-risk PCI procedures.
Watch the Philips #EuroPCR2023 symposium recording. to.philips/6011PySgB Learn how to adopt ultra-low contrast in high-risk PCI procedures.
Why didn’t PCI improve outcomes in REVIVED? A discussion between @divaka_perera and Flávio Ribichini #europcr2023 on the mechanisms at play, including arrhythmia, LV recovery and hibernation … as well as an introduction to @CHIP_BCIS3, a RCT of elective LV unloading in HR-PCI
Why didn’t PCI improve outcomes in REVIVED? A discussion between @divaka_perera and Flávio Ribichini #europcr2023 on the mechanisms at play, including arrhythmia, LV recovery and hibernation … as well as an introduction to @CHIP_BCIS3, a RCT of elective LV unloading in HR-PCI
Feeling inspired and grateful at the mandatory congress! #EuroPCR2023 An incredible opportunity to learn from the world's best interventional cardiologists and share our experiences with everyone. Thankful for this enriching experience! #EuroPCR #MedicalAdvancements
Angioplastie sur tronc commun: un risque d’ischémie résiduelle non négligeable #EuroPCR2023 ms.spr.ly/6016gUDtQ
Angioplastie sur tronc commun: un risque d’ischémie résiduelle non négligeable #EuroPCR2023 ms.spr.ly/6015gUDtt
EuroPCR 2023'te yayınlanan önemli çalışmaların özetlerini içeren elektronik bültenimizin yeni sayısını sizlerle paylaşmaktan mutluluk duyuyoruz. #EuroPCR2023 #TKDGenç #TürkKardiyolojiDerneği Okumak için linke tıklayınız 🔗 tkd.org.tr/tkdgenc/
At #EuroPCR2023, experts presented data from studies including BIOADAPTOR RCT, BENCHMARK, ADALA, and MITRAL. View these slides and news coverage on TCTMD: tctmd.com/conference/eur…
【#EuroPCR2023】スウェーデンの全国的なレジストリーであるSCAARより、慢性冠症候群（CCS）患者において、FFRのカットオフ値0.80で血行再建の有無を決定すると、薬物療法で治療された患者と比較して血行再建を受けた患者で1年の全死亡/TVRの割合が有意… ( 続きはリンクへ ) tcross.co.jp/meeting/europc…
A novel #drug-elutingscaffold was noninferior to a current-generation #DES in terms of #TLF and improved restoration of vessel motion and function at 1 year, according to new randomized trial results. Read more from #EuroPCR2023 on #CRTonline. ow.ly/pVy950OCgbX
The TRILUMINATE pivotal trial results show #TEER for patients with symptomatic, severe #tricuspidregurgitation improved quality of life in patients with mostly concomitant, but treated, left-sided #valvedisease. Read more from #EuroPCR2023 on #CRTonline. ow.ly/vCcE50OC6pI
A novel, six-electrode #renaldenervation (RDN) device showed significantly reduced office systolic blood pressure at 6 months post-procedure in patients with uncontrolled #hypertension, according to new randomized trial results. #EuroPCR2023 on #CRTonline. ow.ly/gGiw50OC3C7
In patients with secondary #MR, at 2 years, #TMVR with mostly transapically implanted devices was associated with better outcomes and similar mortality compared with guideline-directed medical therapy alone, a new analysis shows. #EuroPCR2023 #CRTonline. ow.ly/Cr8T50OBmGO
